Metraipolis › archive › dc_62010ff65338
Advances in the Development of SARS-CoV-2 Mpro Inhibitors — Europe PMC PMID:35458721
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35458721
- DOI
- 10.3390/molecules27082523
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T15:16:12.434Z
- SHA-256 of the archived text
9598cebbff6bc9b8bcddc4e02deed577cd30ded10dfa9bb6ca85a54829f046b0- Stable URL of this page
https://metraipolis.com/documento/dc_62010ff65338
How to cite
Advances in the Development of SARS-CoV-2 Mpro Inhibitors — Europe PMC PMID:35458721 — Europe PMC (en), https://europepmc.org/article/MED/35458721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62010ff65338 (Metraipolis archive dc_62010ff65338, sha256 9598cebbff6bc9b8bcddc4e02deed577cd30ded10dfa9bb6ca85a54829f046b0)
BibTeX
@misc{dc62010ff65338,
title = {Advances in the Development of SARS-CoV-2 Mpro Inhibitors — Europe PMC PMID:35458721},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35458721},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62010ff65338; sha256 9598cebbff6bc9b8bcddc4e02deed577cd30ded10dfa9bb6ca85a54829f046b0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35458721. Agents can read the archived copy with the MCP tool read_document.